Fragasso Group Inc. Becton Dickinson & CO Transaction History

Fragasso Group Inc.

  • $1.25 Billion
  • Q4 2024

A detailed history of Fragasso Group Inc. transactions in Becton Dickinson & CO stock. As of the latest transaction made, Fragasso Group Inc. holds 1,064 shares of BDX stock, worth $239,963. This represents 0.02% of its overall portfolio holdings.

Number of Shares
1,064
Previous 999 6.51%
Holding current value
$239,963
Previous $240,000 0.42%
% of portfolio
0.02%
Previous 0.02%

Shares

31 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Jan 13, 2025
BUY
$220.02 - $243.75 $14,301 - $15,843
65 Added 6.51%
1,064 $241,000
Q3 2024

Oct 07, 2024
SELL
$221.47 - $242.41 $190,021 - $207,987
-858 Reduced 46.2%
999 $240,000
Q2 2024

Jul 08, 2024
SELL
$225.07 - $246.17 $49,515 - $54,157
-220 Reduced 10.59%
1,857 $433,000
Q1 2024

Apr 10, 2024
BUY
$233.45 - $247.73 $2,334 - $2,477
10 Added 0.48%
2,077 $513,000
Q4 2023

Jan 08, 2024
BUY
$232.24 - $267.23 $1,393 - $1,603
6 Added 0.29%
2,067 $503,000
Q3 2023

Dec 06, 2023
SELL
$254.9 - $283.59 $20,137 - $22,403
-79 Reduced 3.69%
2,061 $532,000
Q2 2023

Jul 10, 2023
BUY
$238.39 - $265.32 $6,674 - $7,428
28 Added 1.33%
2,140 $564,000
Q1 2023

Apr 13, 2023
SELL
$229.71 - $259.35 $20,673 - $23,341
-90 Reduced 4.09%
2,112 $522,000
Q4 2022

Jan 24, 2023
SELL
$218.29 - $256.91 $480,674 - $565,715
-2,202 Closed
0 $0
Q4 2022

Jan 24, 2023
SELL
$218.29 - $256.91 $57,628 - $67,824
-264 Reduced 10.71%
2,202 $0
Q3 2022

Oct 13, 2022
SELL
$51.03 - $264.23 $24,443 - $126,566
-479 Reduced 16.26%
2,466 $549,000
Q2 2022

Aug 30, 2022
SELL
$234.74 - $275.42 $83,802 - $98,324
-357 Reduced 10.81%
2,945 $726,000
Q1 2022

Apr 06, 2022
SELL
$243.64 - $270.48 $94,045 - $104,405
-386 Reduced 10.47%
3,302 $878,000
Q4 2021

Jan 19, 2022
SELL
$230.08 - $250.94 $227,549 - $248,179
-989 Reduced 21.15%
3,688 $928,000
Q3 2021

Oct 08, 2021
SELL
$232.72 - $256.47 $1.52 Million - $1.68 Million
-6,539 Reduced 58.3%
4,677 $1.15 Million
Q2 2021

Jul 19, 2021
SELL
$232.65 - $254.58 $1.4 Million - $1.53 Million
-6,000 Reduced 34.85%
11,216 $2.73 Million
Q1 2021

May 27, 2021
BUY
$232.09 - $256.88 $314,017 - $347,558
1,353 Added 8.53%
17,216 $4.19 Million
Q4 2020

Feb 04, 2021
BUY
$221.92 - $245.94 $281,616 - $312,097
1,269 Added 8.7%
15,863 $3.97 Million
Q3 2020

Nov 05, 2020
BUY
$215.77 - $276.76 $115,005 - $147,513
533 Added 3.79%
14,594 $3.4 Million
Q2 2020

Aug 10, 2020
BUY
$219.9 - $263.41 $153,710 - $184,123
699 Added 5.23%
14,061 $3.61 Million
Q1 2020

May 14, 2020
SELL
$195.69 - $279.01 $4,696 - $6,696
-24 Reduced 0.18%
13,362 $3.07 Million
Q4 2019

Feb 13, 2020
BUY
$236.45 - $266.82 $197,435 - $222,794
835 Added 6.65%
13,386 $3.64 Million
Q3 2019

Nov 13, 2019
BUY
$230.58 - $256.08 $51,419 - $57,105
223 Added 1.81%
12,551 $3.18 Million
Q2 2019

Aug 13, 2019
BUY
$217.4 - $246.08 $284,576 - $322,118
1,309 Added 11.88%
12,328 $3.11 Million
Q1 2019

May 08, 2019
BUY
$206.05 - $248.17 $429,614 - $517,434
2,085 Added 23.34%
11,019 $2.75 Million
Q4 2018

Feb 12, 2019
BUY
$204.73 - $257.93 $196,336 - $247,354
959 Added 12.03%
8,934 $2.01 Million
Q3 2018

Nov 13, 2018
BUY
$233.07 - $256.0 $228,874 - $251,392
982 Added 14.04%
7,975 $1.88 Million
Q2 2018

Aug 01, 2018
SELL
$208.1 - $233.85 $46,198 - $51,914
-222 Reduced 3.08%
6,993 $1.68 Million
Q1 2018

May 14, 2018
BUY
$205.46 - $240.27 $14,793 - $17,299
72 Added 1.01%
7,215 $1.56 Million
Q4 2017

Feb 09, 2018
BUY
$189.0 - $222.64 $202,986 - $239,115
1,074 Added 17.7%
7,143 $1.53 Million
Q3 2017

Nov 13, 2017
BUY
$186.89 - $198.9 $1.13 Million - $1.21 Million
6,069
6,069 $1.19 Million

Others Institutions Holding BDX

# of Institutions
1,803
Shares Held
260M
Call Options Held
1.27M
Put Options Held
1.09M
View Full List

About BECTON DICKINSON & CO

BDX Quotes by TradingView
  • Ticker BDX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 285,195,008
  • Market Cap $64.3B
  • Description
  • Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. The company's BD Medical segment offers peripheral intravenou...
More about BDX
Track This Portfolio

Track Fragasso Group Inc. Portfolio

Follow Fragasso Group Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Fragasso Group Inc., based on Form 13F filings with the SEC.

News

Stay updated on Fragasso Group Inc. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email